로딩 중…
지수 로딩 중…
IDEAYA Biosciences, Inc.
IDYA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$35.40-0.28%
2026-08-03
Financials
Valuation Metrics
IDEAYA Biosciences, Inc.'s Market Cap is $3.11B. At end of 2025 it was $3.06B. Ranked #1724 of 3,111 in US market (top 55%), #616 of 1,445 on NASDAQ (top 43%), #104 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 39%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $3.11B | US#1,724/3,111 Sec#104/269 |
| Revenue | $225M | US#2,653/3,111 Sec#108/269 |
| Net Income | $-140M | US—/3,111 Sec—/269 |
| Total Assets | $1.03B | US#2,441/3,111 Sec#98/269 |
| Net Assets | $937M | US#1,830/3,111 Sec#69/269 |
| Value | ||
| P/B | 3.32x | US#1,816/3,111 Sec#104/269 |
| P/S | 13.81x | US#2,747/3,111 Sec#133/269 |
| FCF Yield | -2.83% | US—/3,111 Sec—/269 |
| Profitability | ||
| ROE | -14.94% | US#2,472/3,111 Sec#94/269 |
| ROA | -13.59% | US#2,705/3,111 Sec#113/269 |
| Op. Margin | -81.44% | US#2,812/3,111 Sec#120/269 |
| Revenue Growth | 3024.43% | US#13/3,111 Sec#5/269 |
| Financial Health | ||
| Debt Ratio | 9.93% | US#108/3,111 Sec#49/269 |
| Total Debt | $29M | US#2,680/3,111 Sec#171/269 |
| FCF | $-88M | US#2,569/3,111 Sec#141/269 |
| Cash | $158M | US#1,906/3,111 Sec#144/269 |
| Current Ratio | 10.74x | US#228/3,111 Sec#77/269 |
| Performance | ||
| 1Y Return | 45.86% | US#786/3,111 Sec#130/269 |
| 1M Return | -5.98% | US#1,766/3,111 Sec#117/269 |
| From 52W High | -12.76% | US#1,170/3,111 Sec#76/269 |
| 1Y MDD | -27.10% | US#1,153/3,111 Sec#67/269 |
| Trading | ||
| Volume | 376,083 shares | US#2,080/3,111 Sec#208/269 |
| Trading Value | $13M | US#2,023/3,111 Sec#152/269 |
| Per Share | ||
| EPS | $-1.28 | US—/3,111 Sec—/269 |
| BPS | $11.55 | US#1,691/3,111 Sec#56/269 |